Zdrowie i gospodarka · 12/03/2018

FDA Announces Draft Guidance for Proprietary Names of New Animal Drugs

The Food and Drug Administration (FDA) has released a draft guidance for industry outlining recommendations for developing proprietary names for new animal drugs to prevent medication errors and ensure safe use, with a proposed framework for evaluating proposed names and a process for requesting CVM review.